Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Thai Nakarin Hospital PCLBKK:TNH +0.88%86 EV-to-EBITDA is 6.16 as of Aug. 21, 2026, which is 44% below its 10-year median of 10.92. GuruFocus rates BKK:TNH with a GF Score™ of 86/100 and a GF Value™ of ฿36.31 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 512 Healthcare Providers & Services companies, Thai Nakarin Hospital PCL ranks better than 78.52% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Thai Nakarin Hospital PCL's enterprise value is ฿3,284 Mil.
Thai Nakarin Hospital PCL's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 was ฿533 Mil. Therefore, Thai Nakarin Hospital PCL's EV-to-EBITDA for today is 6.16.
The historical rank and industry rank for Thai Nakarin Hospital PCL's EV-to-EBITDA or its related term are showing as below:
BKK:TNH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.84 Med: 10.92 Max: 16.97
Current: 6.15
During the past 13 years, the highest EV-to-EBITDA of Thai Nakarin Hospital PCL was 16.97. The lowest was 5.84. And the median was 10.92.
BKK:TNH's EV-to-EBITDA is ranked better than 78.52% of 512
companies
in the Healthcare Providers & Services industry
Industry Median: 10.6
vs BKK:TNH: 6.15
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Thai Nakarin Hospital PCL's PE Ratio (TTM) for today is calculated as:
Thai Nakarin Hospital PCL's share price for today is ฿28.75.
Thai Nakarin Hospital PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿1.808.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Thai Nakarin Hospital PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thai Nakarin Hospital PCL EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Thai Nakarin Hospital PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Thai Nakarin Hospital PCL's EV-to-EBITDA falls into.
Thai Nakarin Hospital PCL's current Enterprise Value is ฿3,284 Mil.
Thai Nakarin Hospital PCL's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿533 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thai Nakarin Hospital PCL (BKK:TNH) has a EV-to-EBITDA of 6.16 as of Aug. 21, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Thai Nakarin Hospital PCL. This is 44% below median its historical median of 10.92. Over the past decade, Thai Nakarin Hospital PCL's EV-to-EBITDA has ranged from 5.84 to 16.97. According to the industry distribution chart, Thai Nakarin Hospital PCL ranks #110 out of 512 companies in the Healthcare Providers & Services industry, placing it in the top 21.5%.
Is Thai Nakarin Hospital PCL's EV-to-EBITDA too high?
Thai Nakarin Hospital PCL's current EV-to-EBITDA of 6.16 is 44% below median its 10-year median of 10.92. Over the past 10 years, this metric has ranged from a low of 5.84 to a high of 16.97. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.60. Thai Nakarin Hospital PCL's value of 6.16 is 41.9% below this industry median. Based on the distribution chart, Thai Nakarin Hospital PCL ranks #110 out of 512 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Thai Nakarin Hospital PCL has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Thai Nakarin Hospital PCL's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Thai Nakarin Hospital PCL ranks #110 out of 512 companies for EV-to-EBITDA. This places Thai Nakarin Hospital PCL in the top 22% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 10.60. Thai Nakarin Hospital PCL's value of 6.16 is 41.9% below this benchmark. Historically, Thai Nakarin Hospital PCL's own EV-to-EBITDA has ranged from 5.84 to 16.97 over the past decade. While the company's 10-year median is 10.92 vs. the industry median of 10.60, Thai Nakarin Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.60, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Thai Nakarin Hospital PCL's current EV-to-EBITDA of 6.16 is 41.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Thai Nakarin Hospital PCL. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thai Nakarin Hospital PCL's current EV-to-EBITDA is 6.16, which is 44% below median its own 10-year median of 10.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thai Nakarin Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Thai Nakarin Hospital PCL (BKK:TNH) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿36.31, compared to a current price of ฿28.75 — trading 20.8% below its estimated fair value. The current EV-to-EBITDA is 6.16, which is 44% below median its 10-year median of 10.92 and 41.9% below the Healthcare Providers & Services industry median of 10.60. Thai Nakarin Hospital PCL's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Thai Nakarin Hospital PCL (BKK:TNH), the current EV-to-EBITDA is 6.16 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Thai Nakarin Hospital PCL (BKK:TNH) Overvalued in 2026?
Based on GuruFocus' analysis, Thai Nakarin Hospital PCL stock appears to be undervalued.
The current stock price of ฿28.75 is trading 20.8% below its estimated GF Value™ of ฿36.31.
GuruFocus considers Thai Nakarin Hospital PCL to be Modestly Undervalued.
Key valuation signals for BKK:TNH:
EV-to-EBITDA: 6.16 (44% below median its 10-year median of 10.92)
GF Value™: ฿36.31 vs. price of ฿28.75 (20.8% below fair value)
Industry Position: 41.9% below the Healthcare Providers & Services median (#110 of 512)
No single metric tells the full story. See the BKK:TNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Thai Nakarin Hospital PCL operates a general hospital in Thailand. It provides inpatient and outpatient services and medical services. The company's operating units consist of an emergency department, X-ray unit, pharmacy department, physical therapy department, laboratory department, and others.
86GF Score
Get the complete analysis for BKK:TNH
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TNH has been successfully added to your 
